A Phase II Study of VEGF-Trap [afilbercept] in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas.
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2014
At a glance
- Drugs Aflibercept (Primary)
- Indications Gynaecological cancer; Soft tissue sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Nov 2006 Status change